Lights, Cancer, Action! Sahmyook University Researchers Develop a Light-Responsive Novel Drug Delivery System Against Skin Cancer
SEOUL, South Korea, Jan. 25, 2024 /PRNewswire/ -- Nanotechnology-based drug delivery systems (DDS) offer several advantages, such as enhanced bioavailability and controlled drug release with reduced dosage. Recently, Sahmyook University researchers have developed a light-responsive DDS to treat skin cancer. By incorporating gold nanorods into the matrix of nanofibers, the study demonstrates external control over the release of anticancer drugs in a sequential and controlled method. This innovative DDS holds promise for future real-life nanotech-based applications in healthcare.
- SEOUL, South Korea, Jan. 25, 2024 /PRNewswire/ -- Nanotechnology-based drug delivery systems (DDS) offer several advantages, such as enhanced bioavailability and controlled drug release with reduced dosage.
- Recently, Sahmyook University researchers have developed a light-responsive DDS to treat skin cancer.
- In this light, a team of researchers led by Professor Myoung-Hwan Park from Sahmyook University in South Korea has developed a light-responsive nanofiber-based novel drug delivery system (DDS) targeting skin cancer.
- Accordingly, the integration of nanofibers with on-demand drug delivery systems can open up new possibilities for drug therapy."